Clearside Biomedical (CLSD) Misses Q1 EPS by 2c

Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.

You May Also Be Interested In

• OpenAI's Altman: rise in cost of compute and memory definitely a headwind - CNBC Interview
• Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
• Goldman Sachs Upgrades Amorepacific Corp (090430:KS) (AMRPF) to Buy